The global pollen allergy industry is currently valued at US$ 5850.8 Million in 2023 and is anticipated to expand at a CAGR of 4.2%. Owing to the technological advances in healthcare the market is likely to propel to US$ 8828.6 Million by 2033. The rise in number of patients suffering from pollen-based allergies and more precisely hay fever …
Category Archives: Healthcare Trends
Pharmacy Automation Systems Industry Fueling a Remarkable 8.0% CAGR, Poised to Reach US$ 10.6 Billion by 2032 | FMI’s Projections Unveiled
In 2022, the global pharmacy automation systems industry is set to be valued at US$ 4.9 billion, and this impressive trajectory is expected to persist. Anticipating a Compound Annual Growth Rate (CAGR) of 8.0% from 2022 to 2032, the market is forecasted to culminate at a remarkable US$ 10.6 billion by 2032. The surging demand for pharmacy …
Vascular Closure Devices Industry Grows at 5.30% CAGR, Anticipating US$2.47 Billion by 2033 | FMI’s Insightful Report
The vascular closure devices industry is in the midst of remarkable growth and transformation, evident both in its current market value and the expected trends. As of 2023, the market has surged to a valuation of approximately US$ 1,468.4 million, emphasizing the escalating demand for vascular closure devices. Looking forward to 2033, the market is on the …
Compression Garments and Stockings Industry at 4.9% CAGR, Expected to Reach US$ 3.9 Billion by 2029 | FMI
As per FMI’s analysis, the worldwide market for compression garments and stockings is poised for significant expansion, with a projected Compound Annual Growth Rate (CAGR) of 4.9%. This growth is expected to elevate the market’s value from US$ 2.8 Billion in 2022 to an estimated US$ 3.9 Billion by 2029. The increasing frequency of new product launches, …
Dengue Vaccines Industry Soars with 12.9% CAGR to Reach US$1603.7 Million by 2033 | FMI Insights
The dengue vaccine industry is on a promising growth trajectory, with an estimated valuation of US$ 474.8 million in 2023. Anticipated demand for dengue vaccines is set to surge, with a projected sales volume CAGR of 12.9%. Dengue vaccine development has reached a pivotal phase in its lifecycle, marked by several pharmaceutical industry leaders poised to unveil …
Middle East Veterinary Vaccines Industry Targets US$533.4 Million by 2031 with a 4.8% CAGR | FMI
The Middle East Veterinary Vaccines Industry, with a valuation of US$ 335.0 Million in 2021, is poised for substantial growth, projected to achieve US$ 533.4 Million by 2031. This growth reflects a cumulative Compound Annual Growth Rate (CAGR) of 4.8% throughout the forecast period spanning from 2022 to 2031, as per the comprehensive study conducted by …
Branded Generics Industry Forecasted to Achieve a 8.6% CAGR, Reaching US$747.2 Million by 2033
In 2023, the dynamic world of the branded generics industry will be valued at an impressive US$327.8 million. Looking ahead, the branded generics sector is set to skyrocket to an estimated US$747.2 million by 2033, boasting a compelling CAGR of 8.6% throughout the forecast period. Branded generics represent the latest incarnations of off-patent pharmaceuticals, masterfully crafted by …
Empty Capsules Industry’s Remarkable Journey Towards US$4.9 Billion in 2033 | Reveals by FMI
The global market for empty capsules is on a promising growth trajectory, with projected sales set to reach an impressive US$2.3 billion by 2023. This expansion is expected to persist with a steady compound annual growth rate (CAGR) of 7.9% from 2023 to 2033, culminating in a market value of US$4.9 billion. The surging demand for empty …
Global Peptide Therapeutics Industry on a Steady Upward Trajectory: Exploring the 10.8% CAGR and US$106 Billion Outlook for 2023 to 2033 | FMI Insights
The Global Peptide Therapeutics Industry has surged to a staggering valuation of US$38 billion in 2023 and is poised to reach an impressive US$106 billion by 2033. This remarkable growth is being driven by a robust compound annual growth rate (CAGR) of 10.8% over the forecast period. Notably, peptide therapeutics currently dominate 53.7% of the …
Oncolytic Adenovirus Market Targets US$ 250 Billion Valuation by 2033 | Future Market Insights,Inc.
During the forecast period 2023 to 2033, the oncolytic adenovirus market is expected to grow at a value of 7.5% CAGR, according to Future Market Insights. By the year 2033, the global market for oncolytic adenovirus is expected to rise up to a market valuation of US$ 250 Billion. Growth of the market can be attributed to …